Background and study aims: Endoscopic ultrasonography (EUS) is generally established as the most sensitive diagnostic tool for the assessment of locoregional tumor stage in esophageal carcinoma. It therefore has a crucial impact on the decision whether patients should undergo surgery as primary treatment or should receive neoadjuvant therapy. This study retrospectively evaluates the accuracy of EUS in tumor and nodal staging of prospectively evaluated patients with esophageal carcinoma in relation to tumor type, tumor grading, tumor site, and the influence of dilation.
Patients and methods: All 214 patients included in the study underwent surgery without neoadjuvant therapy and had tumor-free resection margins with no evidence of distant metastasis. EUS investigations were done at our Department of Interdisciplinary Endoscopy. EUS results were compared with the pathological findings.
Results: EUS correctly identified T status in 141 patients (65.9 %). The sensitivity and specificity in relation to T status were 68.1 % and 98.2 % respectively for T1, 40.9 % and 83.4 % for T2, 84.3 % and 64.6 % for T3, and 14.3 % and 98.8 % for T4. The overall diagnostic accuracy of EUS in relation to N status was 64.5 % (n = 138); sensitivity and specificity for the diagnosis of N1 were 93.8 % and 20 %, respectively. Sixty-eight (80 %) of 85 pN0-staged tumors were overstaged as uN1. Dilation had a significant influence on the accuracy of EUS staging in advanced tumors (P = 0.02), whereas tumor grading impacted on EUS staging in early tumors (P = 0.01). Tumor site and tumor type did not show any influence.
Conclusions: Endosonographic staging of esophageal carcinoma is still unsatisfactory. An improvement in staging accuracy may be achieved by adding fine-needle aspiration biopsy (FNA) to EUS, because FNA improves N-stage accuracy, but it has no bearing on T-stage accuracy.
References
-
1
Altorki N.
Should en bloc esophagectomy be the standard of care for esophageal carcinoma?.
Ann Surg.
2001;
234
581-587
-
2
Stein H, Feith M, Bruecher B. et al .
Early esophageal cancer - pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection.
Ann Surg.
2005;
242
566-575
-
3
Ando N, Ozawa S, Kitagawa Y. et al .
Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.
Ann Surg.
2000;
232
225-232
-
4
Hofstetter W, Swisher S G, Correa A M. et al .
Treatment outcomes of resected esophageal cancer.
Ann Surg.
2002;
236
376-384; discussion 384-385
-
5
Stein H J, Siewert J R.
Improved prognosis of resected esophageal cancer.
World J Surg.
2004;
28
520-525
-
6
Savoy A D, Wallace M B.
EUS in the management of the patient with dysplasia in Barrett’s esophagus.
J Clin Gastroenterol.
2005;
39
263-267
-
7
Romagnuolo J, Scott J, Hawes R H. et al .
Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer.
Gastrointest Endosc.
2002;
55
648-654
-
8
Botet J F, Lightdale C J, Zauber A G. et al .
Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT.
Radiology.
1991;
181
419-425
-
9
Caletti G, Ferrari A.
Endoscopic ultrasonography.
Endoscopy.
1996;
28
156-173
-
10
Rasanen J V, Sihvo E I, Knuuti M J. et al .
Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.
Ann Surg Oncol.
2003;
10
954-960
-
11
Davies A R, Deans D A, Penman I. et al .
The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer.
Dis Esophagus.
2006;
19
496-503
-
12 Sobon L H, Wittekind C. UICC TNM classification of malignant tumors. 5th edn. New York; Wiley-Liss 1997
-
13
Binmoeller K F, Seifert H, Seitz U. et al .
Ultrasonic esophagoprobe for TNM staging of highly stenosing esophageal carcinoma.
Gastrointest Endosc.
1995;
41
547-552
-
14
Vazquez-Sequeiros E, Wiersema M J, Clain J E. et al .
Impact of lymph node staging on therapy of esophageal carcinoma.
Gastroenterology.
2003;
125
1626-1635
-
15 Lehmann E. Testing statistical hypotheses. 2nd edn. New York; John Wiley 1986
-
16
Lowe V J, Booya F, Fletcher J G. et al .
Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.
Mol Imaging Biol.
2005;
7
422-430
-
17
Rösch T, Lorenz R, Zenker K. et al .
Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography.
Gastrointest Endosc.
1992;
38
460-467
-
18
Holscher A H, Dittler H J, Siewert J R.
Staging of squamous esophageal cancer: accuracy and value.
World J Surg.
1994;
18
312-320
-
19
Botet J F, Lightdale C J, Zauber A G. et al .
Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT.
Radiology.
1991;
181
419-425
-
20
Meining A, Rösch T, Wolf A. et al .
High interobserver variability in endosonographic staging of upper gastrointestinal cancers.
Z Gastroenterol.
2003;
41
391-394
-
21
Siewert J R, Dittler H J.
Esophageal carcinoma: impact of staging on treatment.
Endoscopy.
1993;
25
28-32
-
22
Baba M, Aikou T, Natsugoe S. et al .
Lymph node and perinodal tissue tumor involvement in patients with esophagectomy and three-field lymphadenectomy for carcinoma of the esophagus.
J Surg Oncol.
1997;
64
12-16
-
23
Feith M, Stein H J, Siewert J R.
Pattern of lymphatic spread of Barrett’s cancer.
World J Surg.
2003;
27
1052-1057
-
24
Wang L S, Chow K C, Chi K H. et al .
Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
Am J Gastroenterol.
1999;
94
1933-1940
-
25
Wallace M B, Nietert P J, Earle C. et al .
An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy.
Ann Thorac Surg.
2002;
74
1026-1032
J. R. Izbicki, MD
Department of General, Visceral and Thoracic Surgery
University Medical Centre of Hamburg-Eppendorf
Martinistraße 52
20246 Hamburg
Germany
Fax: +49-40-428034995
Email: izbicki@uke.uni-hamburg.de
